Salem Capital Management Inc Pfizer Inc Transaction History

Salem Capital Management Inc

$126 Million
Q3 2022

A detailed history of Salem Capital Management Inc transactions in Pfizer Inc stock. As of the latest transaction made, Salem Capital Management Inc holds 138,274 shares of PFE stock, worth $3.47 Million. This represents 4.79% of its overall portfolio holdings.

Number of Shares

138,274

Previous 138,274 -0.0%

Holding current value

$3.47 Million

Previous $7.25 Million 16.54%

% of portfolio

4.79%

Previous 5.29%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 27, 2022	SELL	$46.53 - $55.17 $145,545 - $172,571	-3,128 Reduced 2.21%	138,274 $7.25 Million
Q1 2022 Apr 07, 2022	SELL	$45.75 - $56.69 $50,325 - $62,359	-1,100 Reduced 0.77%	141,402 $7.32 Million
Q4 2021 Jan 18, 2022	SELL	$41.32 - $61.25 $27,560 - $40,853	-667 Reduced 0.47%	142,502 $8.42 Million
Q3 2021 Oct 12, 2021	SELL	$39.25 - $50.42 $190,362 - $244,537	-4,850 Reduced 3.28%	143,169 $6.16 Million
Q2 2021 Jul 13, 2021	BUY	$35.91 - $40.68 $345,633 - $391,545	9,625 Added 6.95%	148,019 $5.8 Million
Q1 2021 Apr 15, 2021	BUY	$33.49 - $37.77 $212,661 - $239,839	6,350 Added 4.81%	138,394 $5.01 Million
Q4 2020 Jan 12, 2021	BUY	$33.47 - $42.56 $12,283 - $15,619	367 Added 0.28%	132,044 $4.86 Million
Q3 2020 Oct 13, 2020	SELL	$31.75 - $37.25 $281,019 - $329,699	-8,851 Reduced 6.3%	131,677 $4.83 Million
Q1 2020 Apr 14, 2020	SELL	$27.03 - $38.62 $348,687 - $498,197	-12,900 Reduced 8.41%	140,528 $4.59 Million
Q4 2019 Jan 09, 2020	SELL	$32.92 - $37.36 $72,424 - $82,192	-2,200 Reduced 1.41%	153,428 $6.01 Million
Q3 2019 Oct 07, 2019	SELL	$32.49 - $42.13 $117,776 - $152,721	-3,625 Reduced 2.28%	155,628 $5.59 Million
Q2 2019 Jul 09, 2019	SELL	$36.98 - $41.52 $284,561 - $319,496	-7,695 Reduced 4.61%	159,253 $6.9 Million
Q1 2019 Apr 15, 2019	SELL	$37.5 - $41.2 $88,125 - $96,820	-2,350 Reduced 1.39%	166,948 $7.09 Million
Q4 2018 Jan 08, 2019	SELL	$38.47 - $43.86 $15,388 - $17,544	-400 Reduced 0.24%	169,298 $7.39 Million
Q3 2018 Oct 09, 2018	SELL	$34.47 - $41.81 $43,845 - $53,182	-1,272 Reduced 0.74%	169,698 $7.48 Million
Q2 2018 Jul 09, 2018	SELL	$32.98 - $35.16 $49,469 - $52,739	-1,500 Reduced 0.87%	170,970 $6.2 Million
Q1 2018 Apr 09, 2018	BUY	$31.91 - $37.02 $25,559 - $29,653	801 Added 0.47%	172,470 $6.12 Million
Q4 2017 Jan 16, 2018	SELL	$33.26 - $35.29 $438,998 - $465,792	-13,199 Reduced 7.14%	171,669 $6.22 Million
Q3 2017 Oct 10, 2017	BUY	$31.0 - $34.15 $5.73 Million - $6.31 Million	184,868	184,868 $6.6 Million

Others Institutions Holding PFE

# of Institutions

3,256

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $141B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Salem Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Salem Capital Management Inc with notifications on news.

Account

Salem Capital Management Inc Pfizer Inc Transaction History